V2X Congratulates Chief Growth Officer Roger Mason on Confirmation as Director of the National Reconnaissance Office

V2X (NYSE: VVX) announced that Chief Growth Officer Dr. L. Roger Mason Jr. has been confirmed by the U.S. Senate to serve as Director of the National Reconnaissance Office.

Rhea-AI Summary

V2X (NYSE: VVX) announced that Chief Growth Officer Dr. L. Roger Mason Jr. has been confirmed by the U.S. Senate to serve as Director of the National Reconnaissance Office. Mason joined V2X in 2025 and has overseen corporate strategy, business development, technology, marketing, government affairs, and growth operations.

According to V2X, his leadership strengthened the company’s positioning across key national security priorities and opportunities with defense and intelligence customers. The company stated it will announce plans for the Chief Growth Officer role at a later date.

Positive

• Chief Growth Officer confirmed as Director of the National Reconnaissance Office
• V2X reports strengthened positioning in national security priorities under Mason’s leadership
• Leadership role at NRO may enhance V2X’s visibility in defense and intelligence sectors

Negative

• Departure of V2X’s Chief Growth Officer creates a leadership gap in growth functions
• Succession or replacement plan for the Chief Growth Officer role is not yet announced

Argus Aug 17 session

-0.36% close to close Open Argus

Details

News Market Reaction – VVX

On Aug 17, the day this news came out, VVX closed 0.36% below the previous close.

Data tracked by StockTitan Argus for the Aug 17 session.

Key Figures

Publication date: Aug. 17, 2026 Joined V2X: 2025

Publication date

Aug. 17, 2026

Article dateline

Joined V2X

2025

Chief Growth Officer tenure

Historical Context

5 past events · Latest: Aug 10

5 events

1. Aug 10

   Contract award

   24h Move

   -1.8%

   Marine Corps logistics integration contract valued at up to $500 million

2. Aug 05

   Contract award

   24h Move

   -1.0%

   $87 million Navy aircraft component sustainment contract extending through January 2030

3. Aug 04

   Contract award

   24h Move

   -8.8%

   $500 million Air Force C-12 sustainment contract through June 2031

4. Aug 03

   Earnings report

   24h Move

   -8.8%

   Second-quarter results included raised full-year 2026 revenue and earnings guidance

5. Jul 27

   Index inclusion

   24h Move

   +4.5%

   V2X joined the S&P SmallCap 600 Index following the latest rebalancing

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RESTON, Va., Aug. 17, 2026 /PRNewswire/ -- V2X, Inc. (NYSE: VVX), a leading provider of global mission solutions supporting defense, national security and civilian customers, congratulates Chief Growth Officer Dr. L. Roger Mason Jr. on his confirmation by the U.S. Senate to serve as Director of the National Reconnaissance Office.

Since joining V2X in 2025, Mason has led the company's integrated growth organization, overseeing corporate strategy, business development, technology development, marketing and communications, government affairs, competitive intelligence, and growth operations. Under his leadership, V2X strengthened its strategic positioning across key national security priorities and advanced opportunities supporting the evolving needs of defense and intelligence customers.

"Roger has been an exceptional leader, trusted colleague and advocate for our customers and employees," said Jeremy C. Wensinger, President and Chief Executive Officer of V2X. "His strategic vision, integrity and commitment to the national security mission have left a lasting impact on our company. While we will certainly miss his leadership, we are incredibly proud to see him continue his distinguished career in public service. On behalf of the entire V2X team, we congratulate Roger and wish him every success as he leads one of our nation's most important intelligence organizations."

V2X will announce plans regarding the Chief Growth Officer role at a later date.

About V2X
V2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technology. V2X is embedded in all elements of a critical mission's lifecycle to enhance readiness, optimize resource management, and boost security. The company provides innovation spanning national security, defense, civilian, and international markets. With a global team of approximately 16,000 professionals, V2X enables mission success by injecting AI and machine learning capabilities to meet today's toughest challenges across all operational domains.

Investor Contact
Mike Smith, CFA
Vice President, Treasury, Corporate Development and Investor Relations
IR@goV2X.com
719-637-5773

Media Contact
Angelica Spanos Deoudes
Senior Director, Marketing and Communications
Angelica.Deoudes@goV2X.com
571-338-5195

View original content to download multimedia:https://www.prnewswire.com/news-releases/v2x-congratulates-chief-growth-officer-roger-mason-on-confirmation-as-director-of-the-national-reconnaissance-office-302852419.html

SOURCE V2X, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who from V2X (NYSE: VVX) was confirmed as Director of the National Reconnaissance Office?

Dr. L. Roger Mason Jr., V2X’s Chief Growth Officer, was confirmed as Director of the National Reconnaissance Office. According to V2X, he led corporate strategy, business development, technology, marketing, government affairs, and growth operations after joining the company in 2025.

What role did Dr. Roger Mason have at V2X (NYSE: VVX) before his NRO appointment?

Before his NRO appointment, Dr. Mason served as Chief Growth Officer at V2X. According to V2X, he oversaw its integrated growth organization, including strategy, business development, technology development, marketing, government affairs, competitive intelligence, and growth operations.

How does V2X describe Dr. Roger Mason’s impact on the company and VVX shareholders?

V2X describes Dr. Mason as an exceptional leader whose strategic vision strengthened its national security positioning. According to V2X, his leadership advanced opportunities supporting evolving defense and intelligence customer needs, which may be relevant to how investors view the company’s strategic direction.

What are V2X’s plans for the Chief Growth Officer position after Dr. Mason’s confirmation?

V2X has not yet detailed its plans for the Chief Growth Officer position. According to V2X, the company will announce plans for the role at a later date, leaving current succession details undisclosed for now.

Does Dr. Roger Mason’s appointment to the NRO affect V2X’s national security focus?

The announcement highlights Mason’s contribution to V2X’s national security positioning but does not change stated strategy. According to V2X, under his leadership the company strengthened alignment with key national security priorities and defense and intelligence customer needs.

When did Dr. Roger Mason join V2X (NYSE: VVX) before becoming Director of the NRO?

Dr. Roger Mason joined V2X in 2025 before his confirmation as Director of the NRO. According to V2X, during this period he led the company’s integrated growth organization and helped advance opportunities with defense and intelligence customers.